Clinical Research Directory
Browse clinical research sites, groups, and studies.
Endoscopic Pancreatic Duct Stent Placement Versus Conventional Approach in the Treatment of Early Phase Acute Pancreatitis
Sponsor: Almazov National Medical Research Centre
Summary
The planned multicenter randomized study is aimed to assess the efficacy and safety of endoscopic pancreatic duct stenting in adult patients with acute pancreatitis. It is planned to include patients with early-stage nonbiliary pancreatitis in the study.
Official title: Endoscopic Pancreatic Duct Stent Placement Versus Conventional Approach in the Treatment of Early Phase Acute Pancreatitis: International Multicenter Controlled Randomized Prospective Study Protocol
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
200
Start Date
2025-09-01
Completion Date
2027-02-01
Last Updated
2025-07-30
Healthy Volunteers
No
Conditions
Interventions
Endoscopic pancreatic duct stent placement
Endoscopic pancreatic duct stent placement will be performed with a 5Fr Boston Scientific pancreatic stent (3-4 cm in length) within 24 hours from the randomization procedure. The stent will be removed on the 5th day after installation.
Conventional treatment of acute pancreatitis in early phase
Infusion therapy, pain relief, nutritional support and surgical procedure if needed
Locations (7)
Department of General Surgery, Sir Run Run Shaw Hospital
Hangzhou, China
City Clinical Hospital No. 4
Perm, Russia
Almazov National Medical Research Centre
Saint Petersburg, Russia
The City Hospital of the Holy Martyr Elizabeth
Saint Petersburg, Russia
I.I. Dzhanelidze research institute of emergency medicine
Saint Petersburg, Russia
Mariinskaya Hospital
Saint Petersburg, Russia
Volgograd State Medical University
Volgograd, Russia